NantHealth, Inc. (NHIQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0030
+0.0005 (20.00%)
May 12, 2025, 4:00 PM EDT
NantHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2013 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2013 - 2017 |
| Operating Revenue | 67 | 62.63 | 72.96 | 77.43 | 89.46 | Upgrade
|
| Other Revenue | 0 | 0.02 | 0.21 | - | - | Upgrade
|
| Revenue | 67 | 62.65 | 73.17 | 77.43 | 89.46 | Upgrade
|
| Revenue Growth (YoY) | 6.95% | -14.38% | -5.50% | -13.46% | 3.22% | Upgrade
|
| Cost of Revenue | 23.85 | 22.82 | 24.47 | 29.47 | 39.34 | Upgrade
|
| Gross Profit | 43.15 | 39.83 | 48.7 | 47.95 | 50.13 | Upgrade
|
| Selling, General & Admin | 62.5 | 52.09 | 48.53 | 55.6 | 70.76 | Upgrade
|
| Research & Development | 23.05 | 19.71 | 17.27 | 13.93 | 20.92 | Upgrade
|
| Operating Expenses | 94.48 | 80.73 | 74.24 | 78.41 | 100.83 | Upgrade
|
| Operating Income | -51.33 | -40.9 | -25.54 | -30.45 | -50.7 | Upgrade
|
| Interest Expense | -14.12 | -14.48 | -19.2 | -18.04 | -17.12 | Upgrade
|
| Earnings From Equity Investments | - | - | -31.7 | -8.32 | -108.41 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.44 | -3.09 | -10.82 | -5.61 | -16.13 | Upgrade
|
| EBT Excluding Unusual Items | -67.89 | -58.47 | -87.26 | -62.42 | -192.36 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -1.75 | Upgrade
|
| Asset Writedown | -0.21 | - | -0.73 | -3.98 | - | Upgrade
|
| Pretax Income | -68.1 | -58.47 | -87.99 | -66.4 | -194.11 | Upgrade
|
| Income Tax Expense | -0.32 | 0.1 | 0.45 | -1.02 | -3.67 | Upgrade
|
| Earnings From Continuing Operations | -67.78 | -58.57 | -88.44 | -65.38 | -190.43 | Upgrade
|
| Earnings From Discontinued Operations | - | 0.02 | 31.99 | 2.62 | -1.72 | Upgrade
|
| Net Income to Company | -67.78 | -58.54 | -56.45 | -62.76 | -192.15 | Upgrade
|
| Minority Interest in Earnings | - | 0.28 | 0.12 | - | - | Upgrade
|
| Net Income | -67.78 | -58.26 | -56.33 | -62.76 | -192.15 | Upgrade
|
| Net Income to Common | -67.78 | -58.26 | -56.33 | -62.76 | -192.15 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 7 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 7 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | 1.22% | 2.88% | 0.55% | 1.08% | -6.48% | Upgrade
|
| EPS (Basic) | -8.80 | -7.66 | -7.61 | -8.53 | -26.40 | Upgrade
|
| EPS (Diluted) | -8.80 | -7.66 | -7.67 | -8.53 | -26.40 | Upgrade
|
| Free Cash Flow | -38.74 | -32.77 | -22.53 | -13.36 | -40.18 | Upgrade
|
| Free Cash Flow Per Share | -5.03 | -4.31 | -3.04 | -1.81 | -5.52 | Upgrade
|
| Gross Margin | 64.40% | 63.58% | 66.56% | 61.93% | 56.03% | Upgrade
|
| Operating Margin | -76.61% | -65.28% | -34.90% | -39.33% | -56.67% | Upgrade
|
| Profit Margin | -101.16% | -92.99% | -76.98% | -81.06% | -214.78% | Upgrade
|
| Free Cash Flow Margin | -57.81% | -52.31% | -30.79% | -17.25% | -44.91% | Upgrade
|
| EBITDA | -45.46 | -35.05 | -20.2 | -22.6 | -43.07 | Upgrade
|
| EBITDA Margin | -67.86% | -55.95% | -27.61% | -29.18% | -48.15% | Upgrade
|
| D&A For EBITDA | 5.86 | 5.85 | 5.34 | 7.86 | 7.63 | Upgrade
|
| EBIT | -51.33 | -40.9 | -25.54 | -30.45 | -50.7 | Upgrade
|
| EBIT Margin | -76.61% | -65.28% | -34.90% | -39.33% | -56.67% | Upgrade
|
| Revenue as Reported | 67 | 62.65 | 73.17 | 77.43 | 89.46 | Upgrade
|
Updated Nov 22, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.